The Candida Auris Infection Market is expanding steadily as this emerging multidrug-resistant fungus causes outbreaks in healthcare facilities worldwide. Growing demand for rapid diagnostic tests, antifungal therapies, and infection control products is significantly strengthening market growth.As per Market Research Future analysis, the Candida Auris Infection Market Size was estimated at 1.179 USD Billion in 2024. The Candida Auris industry is projected to grow from 1.271 USD Billion in 2025 to 2.705 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 7.84% during the forecast period 2025 - 2035.
Read More Detailed Insights:
www.marketresearchfuture.com/reports/candida-auris-infection-market-35579
Key growth drivers include increasing global spread of C. auris across hospitals and nursing homes, rising antifungal resistance limiting treatment options, and growing investment in novel antifungal drug development. Enhanced surveillance and screening programs, along with improved disinfection protocols, are further contributing to market expansion.
Regionally, North America leads the market due to high outbreak reporting and infection control spending. Europe follows with growing case counts, while the Asia-Pacific region is emerging as surveillance improves and diagnostic capabilities expand.
Related Reports:
[Antibody Reagent Market
India Homeopathy Product Market
Hospital Information System Market
US Liver Biopsy Market
US Glioma Diagnosis Treatment Market
US Ventilation Devices Market
Cordyceps Militaris Market
Collagen and Hyaluronic Acid Intra-Articular Injections Market
India Structural Heart Devices Market